Prostate Cancer - Results from #28200

PSA quo vadis? It is reasonable to start with prostate-specific antigen testing at the age of 40! - Abstract April 20, 2011

EAU 2011 - Oncological outcomes of high-intensity focused ultrasound for localized prostate cancer in 880 consecutive patients - Session Highlights April 20, 2011

EAU 2011 - Race and treatment choice affect cancer specific and overall survival differently in 16,508 men with localized prostate cancer treated in Cancer Research Networks in the United States - Session Highlights April 20, 2011

EAU 2011 - The role of intraoperative frozen section analysis in bilateral nerve-sparing robot-assisted laparoscopic radical prostatectomy for clinically localized prostate cancer - Session Highlights April 20, 2011

EAU 2011 - Monolateral nerve sparing prostatectomy: Review of indications, functional and oncological outcomes - Session Highlights April 20, 2011

Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-Year data from the TROG 96.01 randomised trial - Abstract April 19, 2011

Incidence of prostate cancer in Sri Lanka using cancer registry data and comparisons with the incidence in South Asian men in England - Abstract April 19, 2011

Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer - Abstract April 19, 2011

Effect of urologists and medical oncologists on treatment of elderly men with stage IV prostate cancer - Abstract April 19, 2011

Clinicopathologic features and determinants of Gleason score of prostate cancer in Ghanaian men - Abstract April 19, 2011

Multiphoton microscopy for structure identification in human prostate and periprostatic tissue: Implications in prostate cancer surgery - Abstract April 19, 2011

Do pelvic dimensions and prostate location contribute to the risk of experiencing complications after radical prostatectomy? - Abstract April 19, 2011

The short-term use of erythropoetin-stimulating agents: Impact on the biochemical recurrence of prostate cancer - Abstract April 19, 2011

Radical perineal prostatectomy: An outdated procedure? - Abstract April 19, 2011

Salvage radiation in men after prostate-specific antigen failure and the risk of death - Abstract April 18, 2011

The endocannabinoid system in the cancer therapy: An overview - Abstract April 18, 2011

Prognostic role of perineural invasion in prostate biopsy - Abstract April 18, 2011

Clinically relevant fatigue in recurrence-free prostate cancer survivors - Abstract April 18, 2011

Minireview: Alternative activation pathways for the androgen receptor in prostate cancer - Abstract April 18, 2011

Clinical versus pathologic staging for prostate adenocarcinoma: How do they correlate? - Abstract April 18, 2011

Page 1411 of 1436